<DOC>
	<DOCNO>NCT00043433</DOCNO>
	<brief_summary>The purpose study determine whether T900607-sodium effective safe treat hepatocellular carcinoma , type liver cancer .</brief_summary>
	<brief_title>Study T900607-Sodium Chemotherapy Naive Patients With Hepatocellular Carcinoma .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Inclusion Criteria Histologically cytologically confirm diagnosis HCC ChildPugh liver classification A B Subjects must receive prior chemotherapy radiotherapy HCC At least 18 year age Bidimensionally measurable disease amenable CT scanning . At least one lesion must least 1 X 1 cm size . Karnofsky performance status least 70 % Estimated life expectancy least 12 week Females childbearing potential must negative pregnancy test agree use effective contraceptive Subject must able comply study procedure followup examination . Signed write informed consent Lab Values ( obtain â‰¤ 7 day prior study enrollment ) : ANC least 1.5x10e9/L , Platelet count least 100x10e9/L , Creatinine within 2 time upper limit normal AST ALT within 5 time upper limit normal Bilirubin within 1.5 time upper limit normal Albumin great 2.8 g/dL Exclusion Criteria Severe , concurrent disease , infection comorbidity , judgment investigator , would make subject inappropriate enrollment NYHA Class III/IV cardiac disease , leave ventricular ejection fraction ( LVEF ) &lt; 50 % , acute anginal symptom Patients receive investigational agent within 4 week enrollment Patients pregnant breastfeed History prior malignancy cancer study within last 5 year , except adequately treat basal cell squamous cell skin cancer carcinoma situ cervix History central nervous system metastases carcinomatous meningitis Major surgery within 4 week enrollment Patients receive prior chemotherapy , chemoembolization , immunotherapy , radiotherapy HCC . Prior surgical resection , intratumoral ethanol injection , hormonal therapy , cryosurgery , radiofrequency ablation , selective internal radiation embolization , permit ONLY &gt; 6 week pass since therapy indicator lesion ( &gt; 1 x 1 cm ) outside area prior treatment ( recurrence margin resection allow )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>HCC</keyword>
</DOC>